
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis
Liangliang Ren, Han Chen, Junwei Song, et al.
Theranostics (2019) Vol. 9, Iss. 2, pp. 449-465
Open Access | Times Cited: 109
Liangliang Ren, Han Chen, Junwei Song, et al.
Theranostics (2019) Vol. 9, Iss. 2, pp. 449-465
Open Access | Times Cited: 109
Showing 1-25 of 109 citing articles:
lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling
Jinchang Pan, Shuai Fang, Haihua Tian, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 257
Jinchang Pan, Shuai Fang, Haihua Tian, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 257
MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer
Mohammad Mijanur Rahman, Andrew C. Brane, Trygve O. Tollefsbol
Cells (2019) Vol. 8, Iss. 10, pp. 1214-1214
Open Access | Times Cited: 100
Mohammad Mijanur Rahman, Andrew C. Brane, Trygve O. Tollefsbol
Cells (2019) Vol. 8, Iss. 10, pp. 1214-1214
Open Access | Times Cited: 100
Epigenetics of SFRP1: The Dual Roles in Human Cancers
Rashidah Baharudin, Francis Yew Fu Tieng, Learn‐Han Lee, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 445-445
Open Access | Times Cited: 84
Rashidah Baharudin, Francis Yew Fu Tieng, Learn‐Han Lee, et al.
Cancers (2020) Vol. 12, Iss. 2, pp. 445-445
Open Access | Times Cited: 84
Prospects and challenges of anticancer agents’ delivery via chitosan-based drug carriers to combat breast cancer: a review
Guiqiu Wang, Rilun Li, Benyamin Parseh, et al.
Carbohydrate Polymers (2021) Vol. 268, pp. 118192-118192
Closed Access | Times Cited: 73
Guiqiu Wang, Rilun Li, Benyamin Parseh, et al.
Carbohydrate Polymers (2021) Vol. 268, pp. 118192-118192
Closed Access | Times Cited: 73
Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity
Rui Zhang, Juchuanli Tu, Suling Liu
Seminars in Cancer Biology (2021) Vol. 82, pp. 11-25
Open Access | Times Cited: 62
Rui Zhang, Juchuanli Tu, Suling Liu
Seminars in Cancer Biology (2021) Vol. 82, pp. 11-25
Open Access | Times Cited: 62
Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy
Qiushi Wang, Rebecca Morris, Ann M. Bode, et al.
Cancer Research (2021) Vol. 82, Iss. 6, pp. 949-965
Open Access | Times Cited: 61
Qiushi Wang, Rebecca Morris, Ann M. Bode, et al.
Cancer Research (2021) Vol. 82, Iss. 6, pp. 949-965
Open Access | Times Cited: 61
Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies
Jun Cao, Mengdi Zhang, Bin Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 58
Jun Cao, Mengdi Zhang, Bin Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 58
MiR-377-3p suppresses colorectal cancer through negative regulation on Wnt/β-catenin signaling by targeting XIAP and ZEB2
Lifeng Huang, Zhibo Liu, Jia Hu, et al.
Pharmacological Research (2020) Vol. 156, pp. 104774-104774
Closed Access | Times Cited: 62
Lifeng Huang, Zhibo Liu, Jia Hu, et al.
Pharmacological Research (2020) Vol. 156, pp. 104774-104774
Closed Access | Times Cited: 62
<p>New Advances in Canonical Wnt/β-Catenin Signaling in Cancer</p>
Xiaolan Wen, Yanling Wu, Annoor Awadasseid, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 6987-6998
Open Access | Times Cited: 56
Xiaolan Wen, Yanling Wu, Annoor Awadasseid, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 6987-6998
Open Access | Times Cited: 56
Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action
Kah Min Yap, Mahendran Sekar, Lay-Jing Seow, et al.
Breast Cancer Targets and Therapy (2021) Vol. Volume 13, pp. 471-503
Open Access | Times Cited: 54
Kah Min Yap, Mahendran Sekar, Lay-Jing Seow, et al.
Breast Cancer Targets and Therapy (2021) Vol. Volume 13, pp. 471-503
Open Access | Times Cited: 54
Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway
Zhi Li, Haiyan Yang, Xiaolan Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 34
Zhi Li, Haiyan Yang, Xiaolan Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 34
Vitexin suppresses the proliferation, angiogenesis and stemness of endometrial cancer through the PI3K/AKT pathway
Cuixia Liang, Yongjie Jiang, Lizhu Sun
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 581-589
Open Access | Times Cited: 18
Cuixia Liang, Yongjie Jiang, Lizhu Sun
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 581-589
Open Access | Times Cited: 18
Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma
Shaoshuai Tang, Yunzhi Wang, Rongkui Luo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Shaoshuai Tang, Yunzhi Wang, Rongkui Luo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention
Dipta Sengupta, Moonmoon Deb, Swayamsiddha Kar, et al.
Seminars in Cancer Biology (2020) Vol. 72, pp. 46-64
Closed Access | Times Cited: 44
Dipta Sengupta, Moonmoon Deb, Swayamsiddha Kar, et al.
Seminars in Cancer Biology (2020) Vol. 72, pp. 46-64
Closed Access | Times Cited: 44
The network of non-coding RNAs and their molecular targets in breast cancer
Francesca Crudele, Nicoletta Bianchi, Eva Reali, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 43
Francesca Crudele, Nicoletta Bianchi, Eva Reali, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 43
Long noncoding RNA H19 acts as a miR ‐340‐3p sponge to promote epithelial‐mesenchymal transition by regulating YWHAZ expression in paclitaxel‐resistant breast cancer cells
Yan Lei, Shuo Yang, Chengxu Yue, et al.
Environmental Toxicology (2020) Vol. 35, Iss. 9, pp. 1015-1028
Closed Access | Times Cited: 42
Yan Lei, Shuo Yang, Chengxu Yue, et al.
Environmental Toxicology (2020) Vol. 35, Iss. 9, pp. 1015-1028
Closed Access | Times Cited: 42
MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A
Jin Wang, Lingxia Liu
Journal of Ovarian Research (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 38
Jin Wang, Lingxia Liu
Journal of Ovarian Research (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 38
WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer
Anna Kotrbová, Petra Ovesná, Tomáš Gybeľ, et al.
Theranostics (2019) Vol. 10, Iss. 2, pp. 537-552
Open Access | Times Cited: 39
Anna Kotrbová, Petra Ovesná, Tomáš Gybeľ, et al.
Theranostics (2019) Vol. 10, Iss. 2, pp. 537-552
Open Access | Times Cited: 39
Wnt/β-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons
Nupur Mukherjee, Chinmay Kumar Panda
Clinical Breast Cancer (2020) Vol. 20, Iss. 5, pp. 361-370
Closed Access | Times Cited: 37
Nupur Mukherjee, Chinmay Kumar Panda
Clinical Breast Cancer (2020) Vol. 20, Iss. 5, pp. 361-370
Closed Access | Times Cited: 37
Ginsenoside Compound K Enhances Fracture Healing via Promoting Osteogenesis and Angiogenesis
Lingli Ding, Song Gu, Bingyu Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Lingli Ding, Song Gu, Bingyu Zhou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer
Mandana Azari, Farbod Bahreini, Vladimir N. Uversky, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115459-115459
Closed Access | Times Cited: 11
Mandana Azari, Farbod Bahreini, Vladimir N. Uversky, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115459-115459
Closed Access | Times Cited: 11
Serum exosomal miR-454-3p contributes to malignant progression of lung cancer by inhibiting HHEX
Guoyong Hu, Peng Cai, Jingjing Li, et al.
Molecular and Cellular Probes (2025) Vol. 80, pp. 102019-102019
Closed Access
Guoyong Hu, Peng Cai, Jingjing Li, et al.
Molecular and Cellular Probes (2025) Vol. 80, pp. 102019-102019
Closed Access
The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in prostate cancer
Juan Guzman, Martin Hart, Katrin Weigelt, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Juan Guzman, Martin Hart, Katrin Weigelt, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
<p>Downregulation of miR-216a-5p by long noncoding RNA PVT1 suppresses colorectal cancer progression via modulation of YBX1 expression</p>
Xiang Zeng, Yan Liu, Hongquan Zhu, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 6981-6993
Open Access | Times Cited: 35
Xiang Zeng, Yan Liu, Hongquan Zhu, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 6981-6993
Open Access | Times Cited: 35
The anti‑migration and anti‑invasion effects of Bruceine D in human triple‑negative breast cancer MDA‑MB‑231 cells
Can Luo, Yu Wang, Wei Cheng, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 31
Can Luo, Yu Wang, Wei Cheng, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 31